Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

"Virtual Patients," Medical Countermeasures On FDA Regulatory Science Horizon

This article was originally published in The Pink Sheet Daily

Executive Summary

The agency is planning a library of validated computer models of how patients respond to medical treatments.

You may also be interested in...



FDA Testing Regs Should Be Loosened, Allow More Human Models – Petition

Drug sponsors need less expensive options beyond traditional animal models to fulfill preclinical data requirements, coalition of 14 groups and companies says.

Hamburg "Guardedly Optimistic" On FDA Budget

Addressing FDA's Science Board Advisory Committee, Commissioner Margaret Hamburg says she expects the agency will end up with about the same level of funding as in fiscal 2011.

Hamburg "Guardedly Optimistic" On FDA Budget

Addressing FDA's Science Board Advisory Committee, Commissioner Margaret Hamburg says she expects the agency will end up with about the same level of funding as in fiscal 2011.

Related Content

Topics

Latest News
See All
UsernamePublicRestriction

Register

PS072652

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel